1. Home
  2. CMTL vs PMN Comparison

CMTL vs PMN Comparison

Compare CMTL & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comtech Telecommunications Corp.

CMTL

Comtech Telecommunications Corp.

HOLD

Current Price

$3.47

Market Cap

109.7M

Sector

Technology

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$11.02

Market Cap

115.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMTL
PMN
Founded
1967
2004
Country
United States
Canada
Employees
1385
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
109.7M
115.5M
IPO Year
2024
2022

Fundamental Metrics

Financial Performance
Metric
CMTL
PMN
Price
$3.47
$11.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.00
$42.67
AVG Volume (30 Days)
191.1K
38.9K
Earning Date
06-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$499,528,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.35
$0.29
52 Week High
$6.21
$27.40

Technical Indicators

Market Signals
Indicator
CMTL
PMN
Relative Strength Index (RSI) 38.10 37.05
Support Level $2.78 $10.55
Resistance Level $3.73 $13.80
Average True Range (ATR) 0.27 0.95
MACD 0.00 0.14
Stochastic Oscillator 6.71 14.68

Price Performance

Historical Comparison
CMTL
PMN

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: